LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| Hs 578T | Sorafenib | -0.1124 |
| BT-20 | PD173074 | -0.1002 |
| SK-BR-3 | XL147 | -0.0919 |
| BT-20 | Enzastaurin | -0.0904 |
| SK-BR-3 | Imatinib | -0.0675 |
| SK-BR-3 | Enzastaurin | -0.0642 |
| MCF7 | Imatinib | -0.0522 |
| Hs 578T | PLX-4720 | -0.0435 |
| Hs 578T | SB590885 | -0.0425 |
| SK-BR-3 | Selumetinib | -0.0337 |
| SK-BR-3 | Nilotinib | -0.0290 |
| MCF7 | PD173074 | -0.0281 |
| MCF7 | Gefitinib | -0.0264 |
| BT-20 | Selumetinib | -0.0178 |
| MCF7 | XL147 | -0.0161 |
| SK-BR-3 | PD173074 | -0.0160 |
| BT-20 | Linifanib | -0.0159 |
| Hs 578T | Imatinib | -0.0158 |
| MDA-MB-231 | XL147 | -0.0157 |
| SK-BR-3 | Linifanib | -0.0102 |
| MDA-MB-231 | Gefitinib | -0.0096 |
| BT-20 | NVP-AEW541 | -0.0091 |
| BT-20 | Imatinib | -0.0069 |
| MDA-MB-231 | Enzastaurin | -0.0058 |
| MCF 10A | Imatinib | -0.0040 |